超性腺炎:诊断和治疗方面的进展
Ditte Marie Lindhardt Saunte1, Gregor Borut Ernst Jemec1
1Department of Dermatology, Zealand University Hospital, Roskilde, Denmark; Health Sciences Faculty, University of Copenhagen, Denmark.
JAMA
|November 29, 2017
概括
这是一种常见的皮肤疾病,通常未得到充分的治疗. 最近的进展提供了新的抗生素,生物和手术选择来控制HS的症状并改善患者的结果.
科学领域:
- 皮肤病学
- 免疫学
- 流行病学
背景情况:
- 补腺炎 (HS) 影响0.05%至4.10%的人口.
- 尽管这种疾病很常见,但许多HS患者接受的治疗却不够.
- 这可能导致严重的残疾和并发症,包括肥胖,代谢综合征,糖尿病和关节炎,并与全因死亡率的增加有关.
研究的目的:
- 审查HS的诊断,流行病学和治疗.
- 突出了过去五年在高频率管理方面取得的进展.
主要方法:
- 在2011年9月1日至2017年5月1日期间发表的治疗研究的PubMed,MEDLINE和EMBASE的综合文献搜索.
- 不包括评论,指导方针,会议摘要和不到10名患者的研究.
- 在多个搜索引擎中搜索HS指南.
主要成果:
- 脊髓炎的诊断依赖于病变形态,位置 (例如,下,沟) 和慢性.
- 流行病学数据显示HS比以前估计的更常见.
- 有效的治疗包括组合抗生素 (克林达米辛/里法辛,以埃尔塔因为基础的疗法),阿达利木马布和潜在的IL-1/IL-12向治疗.
- 手术技术和激光治疗对临床结果的证据有限.
结论:
- 腺炎是一种普遍的疾病,需要针对特定的病变类型和位置进行差异诊断.
- 目前和新兴的治疗方法包括药物 (抗生素,生物药物) 和手术.
- 需要进一步研究以确定手术和激光干预的临床结果.
相关概念视频
Chronic Pancreatitis II: Collaborative Care
390
The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
Assessment:
390
Inflammatory Bowel Disease V: Surgical Management
728
Surgical interventions for inflammatory bowel disease (IBD), which includes ulcerative colitis and Crohn's disease, are essential in managing symptoms and addressing complications. The selection of surgical procedures is contingent upon the specific conditions and complications that stem from these illnesses.
Here are some common surgical interventions for IBD:
Here are some common surgical interventions for IBD:
728
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
935
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
935
Appendicitis-II: Diagnostic Studies and Management
604
Diagnosing and managing appendicitis requires a structured and comprehensive approach that spans from initial assessment to postoperative care. Here is an overview of the process:
Diagnosing Appendicitis
It requires a multifaceted approach, starting with a detailed physical examination to pinpoint the location and nature of the pain and identify any associated symptoms. Laboratory tests play a crucial role. A complete Blood Count (CBC) typically reveals leukocytosis (an increased number of...
Diagnosing Appendicitis
It requires a multifaceted approach, starting with a detailed physical examination to pinpoint the location and nature of the pain and identify any associated symptoms. Laboratory tests play a crucial role. A complete Blood Count (CBC) typically reveals leukocytosis (an increased number of...
604
Drugs for Treatment of Diarrhea-Predominant IBS
757
Diarrhea-predominant irritable bowel syndrome (IBS-D) is a subtype of IBS characterized primarily by frequent, loose, or watery stools, abdominal pain, and abdominal discomfort. Therapeutic approaches to managing IBS-D include dietary changes, stress management techniques, and pharmaceutical interventions.
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
757
